Health Bulletin 26/May/2023

Here are the top health stories for the day:

Chintpurni Medical College debarred from admitting MBBS students this academic year

In a major setback to Chintpurni Medical College, Pathankot, the National Medical Commission (NMC) has debarred the institute from admitting fresh MBBS students for the academic year 2023-2024. The Apex medical commission has taken this decision after it found serious deficiencies in the medical college in respect of faculty, patient load, and infrastructure.

For more details, check out the link given below:

Chintpurni Medical College debarred from admitting MBBS students this academic year

Scientists create drug that destroys deadly brain tumors

Researchers at the University of Gothenburg, working with French colleagues, have successfully developed a method able to kill the aggressive brain tumor glioblastoma. By blocking certain functions in the cell with a docked molecule, the researchers caused the cancer to die of stress. The outcomes of the experiments were deemed highly encouraging, as the treated mice remained cured with no signs of recurrence even after a period of over six months. Furthermore, this drug demonstrates its efficacy when used in conjunction with chemotherapy, as compared to its peers who received chemotherapy alone and experienced rapid tumor regrowth and spreading. Glioblastomas, which are often regarded as incurable, require improved treatment options urgently. The international team of researchers believes that this drug could be integrated into clinical practice within a span of five years. Additionally, this groundbreaking discovery has the potential to impact the treatment of other aggressive forms of cancer